- 1.7.2026
- Press Releases
Press Release: Eliza Dushku, Mental Health Counselor and Former Actress, Joins VETS Board of Directors
VETS welcomes former actress and clinical mental health specialist Eliza Dushku to its Board of Directors, bringing her expertise in psychedelic-assisted therapy and unwavering commitment to veteran mental health to further VETS’ mission of ending the veteran suicide epidemic.
- 10.15.2025
- Press Releases
California Governor Newsom Signs AB 1103 to Accelerate Psychedelic Research for Veterans and Mental Health Innovation
Legislation sponsored by VETS will expedite critical research on psychedelic therapies for PTSD, traumatic brain injury, and substance use disorders in California
- 6.17.2025
- Press Releases
- News
Veterans Exploring Treatment Solutions (VETS) Takes Center Stage at Psychedelic Science 2025
Veterans Exploring Treatment Solutions (VETS) brought its mission to the forefront at Psychedelic Science 2025, spotlighting the urgent need for access, equity, and innovation in veteran mental health. From policy advocacy to powerful storytelling, VETS delivered a bold message: healing is a right—and veterans deserve the freedom to pursue it.
- 3.25.2025
- Press Releases
Press Release: VETS Co-Founder & CEO Amber Capone Named to Inc.'s 2025 Female Founders 500 List
Amber Capone, Co-Founder and CEO of VETS, has been named to Inc.'s 2025 Female Founders 500 List. This recognition highlights her significant contributions and leadership in her field.
- 3.12.2025
- Press Releases
Press Release: Veterans Exploring Treatment Solutions (VETS) Leads Legislative Day of Action on March 18, 2025 in Support of Texas Ibogaine Initiative
The Legislative Day of Action aims to educate legislators on the transformative potential of ibogaine-assisted therapy for veterans struggling with OUD, co-occurring SUD, and neurological or mental health conditions, as well as address the critical issue that service members must travel internationally to access these treatments.